4 Sexually Transmitted Disease (STD) Prevention, National Insti- tutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Md, USA, 2001. [5] K. K. Holmes, R. Levine, and M. Weaver, “Eﬀectiveness of condoms in preventing sexually transmitted infections,” Bulletin of the World Health Organization, vol. 82, no. 6, pp. 454–461, 2004. [6] A. M. Foss, P. T. Vickerman, L. Heise, and C. H. Watts, “Shifts in condom use following microbicide introduction: should we be concerned?” Sexually Transmitted Infections, vol. 85, no. 4, pp. 276–282, 2009. [7] M. M. Cassell, D. T. Halperin, J. D. Shelton, and D. Stanton, “Risk compensation: the Achilles’ heel of innovations in HIV prevention?” British Medical Journal, vol. 332, no. 7541, pp. 605–607, 2006. [8] K. Pazol, M. R. Kramer, and C. J. Hogue, “Condoms for dual protection: patterns of use with highly eﬀective contraceptive methods,” Public Health Reports, vol. 125, no. 2, pp. 208–217, 2010. [9] J. S. Santelli, M. Davis, D. D. Celentano, A. D. Crump, and L. G. Burwell, “Combined use of condoms with other contraceptive methods among inner-city Baltimore women,” Family Planning Perspectives, vol. 27, no. 2, pp. 74–78, 1995. [10] C. F. Roye, “Condom use by Hispanic and African-American adolescent girls who use hormonal contraception,” Journal of Adolescent Health, vol. 23, no. 4, pp. 205–211, 1998. [11] A. B. Berenson and C. M. Wiemann, “Use of levonorgestrel implants versus oral contraceptives in adolescence: a case- control study,” American Journal of Obstetrics and Gynecology, vol. 172, no. 4, part 1, pp. 1128–1137, 1995. [12] P. D. Darney, L. S. Callegari, A. Swift, E. S. Atkinson, and A. M. Robert, “Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception,” American Journal of Obstetrics and Gynecology, vol. 180, no. 4, pp. 929–937, 1999. [13] L. F. Cushman, D. Romero, D. Kalmuss, A. R. Davidson, S. Heartwell, and M. Rulin, “Condom use among women choosing long-term hormonal contraception,” Family Plan- ning Perspectives, vol. 30, no. 5, pp. 240–243, 1998. [14] M. Polaneczky, G. Slap, C. Forke, A. Rappaport, and S. Sond- heimer, “The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers,” New England Journal of Medicine, vol. 331, no. 18, pp. 1201–1206, 1994. [15] G. S. Stuart and D. A. Grimes, “Social desirability bias in family planning studies: a neglected problem,” Contraception, vol. 80, no. 2, pp. 108–112, 2009. [16] Institute of the Medicine of the National Academies (IOM), Board on Global Health, “Design Considerations: adherence,” in Methodological Challenges in Biomedical HIV Prevention Trials, S. W. Lagakos and A. R. Gable, Eds., pp. 119–147, The National Academies Press, Washington, DC, USA, 2008. [17] S. M. Noar, C. Cole, and K. Carlyle, “Condom use mea- surement in 56 studies of sexual risk behavior: review and recommendations,” Archives of Sexual Behavior, vol. 35, no. 3, pp. 327–345, 2006. [18] J. A. Catania, D. R. Gibson, D. D. Chitwood, and T. J. Coates, “Methodological problems in AIDS behavioral research: inﬂu- ences on measurement error and participation bias in studies of sexual behavior,” Psychological Bulletin, vol. 108, no. 3, pp. 339–362, 1990. [19] A. M. Minnis, M. J. Steiner, M. F. Gallo et al., “Biomarker validation of reports of recent sexual activity: results of a Infectious Diseases in Obstetrics and Gynecology randomized controlled study in Zimbabwe,” American Journal of Epidemiology, vol. 170, no. 7, pp. 918–924, 2009. [20] J. Aho, A. Koushik, S. L. Diakite´, K. M. Loua, V. K. Nguyen, and S. Rashed, “Biological validation of self-reported condom use among sex workers in Guinea,” AIDS and Behavior, vol. 14, no. 6, pp. 1287–1293, 2009. [21] E. Rose, R. J. Diclemente, G. M. Wingood et al., “The validity of teens’ and young adults’ self-reported condom use,” Archives of Pediatrics and Adolescent Medicine, vol. 163, no. 1, pp. 61–64, 2009. [22] M. F. Gallo, F. M. Behets, M. J. Steiner et al., “Validity of self- reported ’safe sex’ among female sex workers in Mombasa, Kenya—PSA analysis,” International Journal of STD and AIDS, vol. 18, no. 1, pp. 33–38, 2007. [23] M. F. Gallo, F. M. Behets, M. J. Steiner et al., “Prostate-speciﬁc antigen to ascertain reliability of self-reported coital exposure to semen,” Sexually Transmitted Diseases, vol. 33, no. 8, pp. 476–479, 2006. [24] R. A. Jadack, J. Yuenger, K. G. Ghanem, and J. Zenil- man, “Polymerase chain reaction detection of Y-chromosome sequences in vaginal ﬂuid of women accessing a sexually transmitted disease clinic,” Sexually Transmitted Diseases, vol. 33, no. 1, pp. 22–25, 2006. [25] M. F. Gallo, J. D. Sobel, A. M. Rompalo, S. Cu-Uvin, E. Schoenbaum, and D. J. Jamieson, “Discordance between spermatozoa detection and self-reported semen exposure,” Sexually Transmitted Diseases. In press. [26] W. D. Mosher and J. Jones, “Use of contraception in the United States: 1982–2008,” Vital and Health Statistics, vol. 23, no. 29, pp. 1–44, 2010. [27] World Health Organization, Medical Eligibility Criteria for Contraceptive Use, WHO, Geneva, Switzerland, 4th edition, 2010. [28] Centers for Disease Control and Prevention, “U S. Medical Eligibility Criteria for Contraceptive Use, 2010,” Morbidity and Mortality Weekly Report, vol. 59, no. 4, pp. 1–86, 2010. [29] M. Hara, Y. Koyanagi, T. Inoue, and T. Fukuyama, “Some physico-chemical characteristics of ”gamma-seminoprotein”, an antigenic component speciﬁc for human seminal plasma,” Japanese Journal of Legal Medicine, vol. 25, no. 4, pp. 322–324, 1971. [30] M. MacAluso, L. Lawson, R. Akers et al., “Prostate-speciﬁc antigen in vaginal ﬂuid as a biologic marker of condom failure,” Contraception, vol. 59, no. 3, pp. 195–201, 1999. [31] M. Macaluso, M. L. Lawson, G. Hortin et al., “Eﬃcacy of the female condom as a barrier to semen during intercourse,” American Journal of Epidemiology, vol. 157, no. 4, pp. 289–297, 2003. [32] M. Macaluso, R. Blackwell, D. J. Jamieson et al., “Eﬃcacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial,” American Journal of Epidemiology, vol. 166, no. 1, pp. 88–96, 2007. [33] L. W. Galva˜o, L. C. Oliveira, J. D´ıaz et al., “Eﬀectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial,” Contraception, vol. 71, no. 2, pp. 130–136, 2005. [34] M. M. Hobbs, M. J. Steiner, K. D. Rich et al., “Good per- formance of rapid prostate-speciﬁc antigen test for detection of semen exposure in women: implications for qualitative research,” Sexually Transmitted Diseases, vol. 36, no. 8, pp. 501–506, 2009.